<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34440903</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2134</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10082134</ELocationID><Abstract><AbstractText>Non-persistent viruses classically cause transient, acute infections triggering immune responses aimed at the elimination of the pathogen. Successful viruses evolved strategies to manipulate and evade these anti-viral defenses. Symptoms during the acute phase are often linked to dysregulated immune responses that disappear once the patient recovers. In some patients, however, symptoms persist or new symptoms emerge beyond the acute phase. Conditions resulting from previous transient infection are termed post-acute sequelae (PAS) and were reported for a wide range of non-persistent viruses such as rota-, influenza- or polioviruses. Here we provide an overview of non-persistent viral pathogens reported to be associated with diverse PAS, among them chronic fatigue, auto-immune disorders, or neurological complications and highlight known mechanistic details. Recently, the emergence of post-acute sequelae of COVID-19 (PASC) or long COVID highlighted the impact of PAS. Notably, PAS of non-persistent infections often resemble symptoms of persistent viral infections, defined by chronic inflammation. Inflammation maintained after the acute phase may be a key driver of PAS of non-persistent viruses. Therefore, we explore current insights into aberrant activation of innate immune signaling pathways in the post-acute phase of non-persistent viruses. Finally, conclusions are drawn and future perspectives for treatment and prevention of PAS are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirschenberger</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8766-1271</Identifier><AffiliationInfo><Affiliation>Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunszinger</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparrer</LastName><ForeName>Konstantin Maria Johannes</ForeName><Initials>KMJ</Initials><Identifier Source="ORCID">0000-0002-8682-1779</Identifier><AffiliationInfo><Affiliation>Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IMMUNOMOD</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>SP1600/4-1</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>SPP1923</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant><Grant><GrantID>CRC1279</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">acute</Keyword><Keyword MajorTopicYN="N">chronic</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long hauler syndrome</Keyword><Keyword MajorTopicYN="N">post-acute</Keyword><Keyword MajorTopicYN="N">post-acute sequelae</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34440903</ArticleId><ArticleId IdType="pmc">PMC8391718</ArticleId><ArticleId IdType="doi">10.3390/cells10082134</ArticleId><ArticleId IdType="pii">cells10082134</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Takeuchi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2008;227:75&#x2013;86. doi: 10.1111/j.1600-065X.2008.00737.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00737.x</ArticleId><ArticleId IdType="pmc">PMC5489343</ArticleId><ArticleId IdType="pubmed">19120477</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327:291&#x2013;295. doi: 10.1126/science.1183021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1183021</ArticleId><ArticleId IdType="pmc">PMC3645875</ArticleId><ArticleId IdType="pubmed">20075244</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.A., Kagan J.C. Toll-like receptors and the control of immunity. Cell. 2020;180:1044&#x2013;1066. doi: 10.1016/j.cell.2020.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.041</ArticleId><ArticleId IdType="pmc">PMC9358771</ArticleId><ArticleId IdType="pubmed">32164908</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparrer K., Gack M.U. Intracellular detection of viral nucleic acids. Curr. Opin. Microbiol. 2015;26:1&#x2013;9. doi: 10.1016/j.mib.2015.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2015.03.001</ArticleId><ArticleId IdType="pmc">PMC5084527</ArticleId><ArticleId IdType="pubmed">25795286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hale B.G., Albrecht R., Garc&#xed;a-Sastre A. Innate immune evasion strategies of influenza viruses. Futur. Microbiol. 2010;5:23&#x2013;41. doi: 10.2217/fmb.09.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.09.108</ArticleId><ArticleId IdType="pmc">PMC2820251</ArticleId><ArticleId IdType="pubmed">20020828</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkert M. Innate immune evasion by human respiratory RNA viruses. J. Innate Immun. 2019;12:4&#x2013;20. doi: 10.1159/000503030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000503030</ArticleId><ArticleId IdType="pmc">PMC6959104</ArticleId><ArticleId IdType="pubmed">31610541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayn M., Hirschenberger M., Koepke L., Nchioua R., Straub J.H., Klute S., Hunszinger V., Zech F., Bozzo C.P., Aftab W., et al. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep. 2021;35:109126. doi: 10.1016/j.celrep.2021.109126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109126</ArticleId><ArticleId IdType="pmc">PMC8078906</ArticleId><ArticleId IdType="pubmed">33974846</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangalmurti N., Hunter C.A. Cytokine storms: Understanding COVID-19. Immunity. 2020;53:19&#x2013;25. doi: 10.1016/j.immuni.2020.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.017</ArticleId><ArticleId IdType="pmc">PMC7321048</ArticleId><ArticleId IdType="pubmed">32610079</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D.C., June C.H. Cytokine storm. N. Engl. J. Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser L., Fritz R.S., Straus S.E., Gubareva L., Hayden F.G. Symptom pathogenesis during acute influenza: Interleukin-6 and other cytokine responses. J. Med. Virol. 2001;64:262&#x2013;268. doi: 10.1002/jmv.1045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1045</ArticleId><ArticleId IdType="pubmed">11424113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N., Wong C.K., Chan P., Chan M.C.-W., Wong R.Y.K., Lun S.W.M., Ngai K.L.K., Lui C.Y.G., Wong B.C.K., Lee S.K.W., et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS ONE. 2011;6:e26050. doi: 10.1371/journal.pone.0026050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026050</ArticleId><ArticleId IdType="pmc">PMC3192778</ArticleId><ArticleId IdType="pubmed">22022504</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen L., Fiore-Gartland A., Randolph A.G., Panoskaltsis-Mortari A., Wong S.-S., Ralston J., Wood T., Seeds R., Huang Q.S., Webby R.J., et al. A modular cytokine analysis method reveals novel associations with clinical phenotypes and identifies sets of co-signaling cytokines across influenza natural infection cohorts and healthy controls. Front. Immunol. 2019;10:1338. doi: 10.3389/fimmu.2019.01338.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01338</ArticleId><ArticleId IdType="pmc">PMC6594355</ArticleId><ArticleId IdType="pubmed">31275311</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel A.J., Harris S., Marsteller N., Condon S.A., Brown D.M. Early cytokine dysregulation and viral replication are associated with mortality during lethal influenza infection. Viral Immunol. 2014;27:214&#x2013;224. doi: 10.1089/vim.2013.0095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2013.0095</ArticleId><ArticleId IdType="pmc">PMC4043423</ArticleId><ArticleId IdType="pubmed">24787235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Mao J. The pathogenesis and treatment of the &#x201c;Cytokine Storm&#x201d; in COVID-19. J. Infect. 2020;80:607&#x2013;613. doi: 10.1016/j.jinf.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.F., Cotler J., Jason L.A. Post-viral fatigue and COVID-19: Lessons from past epidemics. Fatigue Biomed. Health Behav. 2020;8:61&#x2013;69. doi: 10.1080/21641846.2020.1778227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2020.1778227</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nat. Cell Biol. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole-Wright K., Gaughran F., Evans R., Chalder T. Fatigue outcomes following coronavirus or influenza virus infection: A systematic review and meta-analysis. medRxiv. 2020 doi: 10.1101/2020.12.04.20244145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.04.20244145</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer M. The post-viral syndrome: A review. J. R. Coll. Gen. Pr. 1987;37:212&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1710789</ArticleId><ArticleId IdType="pubmed">3320358</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The lasting misery of coronavirus long-haulers. Nat. Cell Biol. 2020;585:339&#x2013;341. doi: 10.1038/d41586-020-02598-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02598-6</ArticleId><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas M.C. The post-polio syndrome as an evolved clinical entity. Ann. N. Y. Acad. Sci. 1995;753:68&#x2013;80. doi: 10.1111/j.1749-6632.1995.tb27532.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1995.tb27532.x</ArticleId><ArticleId IdType="pubmed">7611661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramlow J., Alexander M., Laporte R., Kaufmann C., Kuller L. Epidemiology of the post-polio syndrome. Am. J. Epidemiol. 1992;136:769&#x2013;786. doi: 10.1093/aje/136.7.769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/136.7.769</ArticleId><ArticleId IdType="pubmed">1442743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K. Chronic Viral Infections in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) BioMed Central Ltd.; London, UK: 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F., Blanco J., Capelli E., Castro-Marrero J., Steiner S., Murovska M., Scheibenbogen C. Myalgic encephalomyelitis/chronic fatigue syndrome&#x2014;Evidence for an autoimmune disease. Autoimmun. Rev. 2018;17:601&#x2013;609. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., Poller W., Kandolf R., Schultheiss H.-P. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with &#x201c;idiopathic&#x201d; left ventricular dysfunction. Circulation. 2005;111:887&#x2013;893. doi: 10.1161/01.CIR.0000155616.07901.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000155616.07901.35</ArticleId><ArticleId IdType="pubmed">15699250</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsch&#xf6;pe C., Ammirati E., Bozkurt B., Caforio A.L.P., Cooper L.T., Felix S.B., Hare J.M., Heidecker B., Heymans S., H&#xfc;bner N., et al. Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. Nat. Rev. Cardiol. 2020;18:169&#x2013;193. doi: 10.1038/s41569-020-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Bijsterveld O.P., Van Hemel O.L. Inflammatory sequelae after adenovirus infection. J. Fr. D&#x2019;ophtalmol. 1988;11:25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">2838542</ArticleId></ArticleIdList></Reference><Reference><Citation>Green P.H.R., Cellier C. Celiac disease. N. Engl. J. Med. 2007;357:1731&#x2013;1743. doi: 10.1056/NEJMra071600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra071600</ArticleId><ArticleId IdType="pubmed">17960014</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison L.C., Perrett K.P., Jachno K., Nolan T.M., Honeyman M.C. Does rotavirus turn on type 1 diabetes? PLoS Pathog. 2019;15:e1007965. doi: 10.1371/journal.ppat.1007965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007965</ArticleId><ArticleId IdType="pmc">PMC6786515</ArticleId><ArticleId IdType="pubmed">31600345</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist M., Juhela S., Erkkil&#xe4; S., Korhonen S., Simell T., Kupila A., Vaarala O., Simell O., Knip M., Ilonen J. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. Clin. Exp. Immunol. 2002;128:511&#x2013;515. doi: 10.1046/j.1365-2249.2002.01842.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2002.01842.x</ArticleId><ArticleId IdType="pmc">PMC1906266</ArticleId><ArticleId IdType="pubmed">12067306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouziat R., Hinterleitner R., Brown J.J., Stencel-Baerenwald J.E., Ikizler M., Mayassi T., Meisel M., Kim S.M., Discepolo V., Pruijssers A.J., et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44&#x2013;50. doi: 10.1126/science.aah5298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah5298</ArticleId><ArticleId IdType="pmc">PMC5506690</ArticleId><ArticleId IdType="pubmed">28386004</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vries R., McQuaid S., Van Amerongen G., Y&#xfc;ksel S., Verburgh R.J., Osterhaus A., Duprex W.P., De Swart R. Measles immune suppression: Lessons from the macaque model. PLoS Pathog. 2012;8:e1002885. doi: 10.1371/journal.ppat.1002885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002885</ArticleId><ArticleId IdType="pmc">PMC3431343</ArticleId><ArticleId IdType="pubmed">22952446</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin D.E., Lin W.-H.W., Nelson A.N. Understanding the causes and consequences of measles virus persistence. F1000Research. 2018;7:237. doi: 10.12688/f1000research.12094.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.12094.1</ArticleId><ArticleId IdType="pmc">PMC5832918</ArticleId><ArticleId IdType="pubmed">29560260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina M.J., Metcalf C.E., De Swart R., Osterhaus A., Grenfell B. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348:694&#x2013;699. doi: 10.1126/science.aaa3662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3662</ArticleId><ArticleId IdType="pmc">PMC4823017</ArticleId><ArticleId IdType="pubmed">25954009</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin D. Measles virus persistence and its consequences. Curr. Opin. Virol. 2020;41:46&#x2013;51. doi: 10.1016/j.coviro.2020.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2020.03.003</ArticleId><ArticleId IdType="pmc">PMC7492426</ArticleId><ArticleId IdType="pubmed">32387998</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddell M., Moss W.J., Hauer D., Monze M., Griffin D.E. Slow clearance of measles virus RNA after acute infection. J. Clin. Virol. 2007;39:312&#x2013;317. doi: 10.1016/j.jcv.2007.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2007.05.006</ArticleId><ArticleId IdType="pubmed">17625962</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg R.K., Mahadevan A., Malhotra H.S., Rizvi I., Kumar N., Uniyal R. Subacute sclerosing panencephalitis. Rev. Med. Virol. 2019;29:e2058. doi: 10.1002/rmv.2058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2058</ArticleId><ArticleId IdType="pubmed">31237061</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson J.B., Cornu T.I., Redwine J., Dales S., Lewicki H., Holz A., Thomas D., Billeter M.A., Oldstone M.B. Evidence that the hypermutated m protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virolgy. 2001;291:215&#x2013;225. doi: 10.1006/viro.2001.1182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1182</ArticleId><ArticleId IdType="pubmed">11878891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng B.-Y., Lim C.T., Yeoh A., Lee W. Neuropsychiatric sequelae of nipah virus encephalitis. J. Neuropsychiatry Clin. Neurosci. 2004;16:500&#x2013;504. doi: 10.1176/jnp.16.4.500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/jnp.16.4.500</ArticleId><ArticleId IdType="pubmed">15616178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar J.J., Hossain J., Saha S.K., Gurley E.S., Banu S., Hamadani J., Faiz M.A., Siddiqui F.M., Mohammad Q.D., Mollah A.H., et al. Long-term neurological and functional outcome in Nipah virus infection. Ann. Neurol. 2007;62:235&#x2013;242. doi: 10.1002/ana.21178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21178</ArticleId><ArticleId IdType="pubmed">17696217</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.T., Goh K.J., Wong K.T., Sarji S.A., Chua K.B., Chew N.K., Murugasu P., Loh Y.L., Chong H.T., Tan K.S., et al. Relapsed and late-onset nipah encephalitis. Ann. Neurol. 2002;51:703&#x2013;708. doi: 10.1002/ana.10212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10212</ArticleId><ArticleId IdType="pubmed">12112075</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D.V., Kibuuka H., Millard M., Wakabi S., Lukwago L., Taylor A., Eller M., Eller L.A., Michael N.L., Honko A., et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: A retrospective cohort study. Lancet Infect. Dis. 2015;15:905&#x2013;912. doi: 10.1016/S1473-3099(15)70152-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)70152-0</ArticleId><ArticleId IdType="pubmed">25910637</ArticleId></ArticleIdList></Reference><Reference><Citation>Diallo M.S.K., Toure A., Sow M.S., Kpamou C., Keita A.K., Taverne B., Peeters M., Msellati P., Barry T.A., Etard J.-F., et al. Understanding the long-term evolution and predictors of sequelae of Ebola virus disease survivors in Guinea: A 48-month prospective, longitudinal cohort study (PostEboGui) Clin. Infect. Dis. 2021 doi: 10.1093/cid/ciab168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab168</ArticleId><ArticleId IdType="pmc">PMC8677527</ArticleId><ArticleId IdType="pubmed">33621316</ArticleId></ArticleIdList></Reference><Reference><Citation>Keita M., Diallo B., Mesfin S., Marega A., Nebie K.Y., Magassouba N., Barry A., Coulibaly S., Barry B., Bald&#xe9; M.O., et al. Subsequent mortality in survivors of Ebola virus disease in Guinea: A nationwide retrospective cohort study. Lancet Infect. Dis. 2019;19:1202&#x2013;1208. doi: 10.1016/S1473-3099(19)30313-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30313-5</ArticleId><ArticleId IdType="pubmed">31494017</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann A., Foucat E., Hocini H., Lefebvre C., Hejblum B.P., Durand M., Kr&#xfc;ger M., Keita A.K., Ayouba A., M&#xe9;ly S., et al. Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nat. Commun. 2020;11:1&#x2013;11. doi: 10.1038/s41467-020-17489-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17489-7</ArticleId><ArticleId IdType="pmc">PMC7381622</ArticleId><ArticleId IdType="pubmed">32709840</ArticleId></ArticleIdList></Reference><Reference><Citation>Fausther-Bovendo H., Qiu X., McCorrister S., Westmacott G., Sandstrom P., Castilletti C., Di Caro A., Ippolito G., Kobinger G.P. Ebola virus infection induces autoimmunity against dsDNA and HSP60. Sci. Rep. 2017;7:srep42147. doi: 10.1038/srep42147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42147</ArticleId><ArticleId IdType="pmc">PMC5299614</ArticleId><ArticleId IdType="pubmed">28181533</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob S., Crozier I., Ii W.A.F., Hewlett A., Kraft C.S., De La Vega M.-A., Soka M.J., Wahl V., Griffiths A., Bollinger L., et al. Ebola virus disease. Nat. Rev. Dis. Prim. 2020;6:1&#x2013;31. doi: 10.1038/s41572-020-0147-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-020-0147-3</ArticleId><ArticleId IdType="pmc">PMC7223853</ArticleId><ArticleId IdType="pubmed">32080199</ArticleId></ArticleIdList></Reference><Reference><Citation>Tozay S., Fischer W., Wohl D., Kilpatrick K., Zou F., Reeves E., Pewu K., Demarco J., Loftis A.J., King K., et al. Long-term complications of Ebola virus disease: Prevalence and predictors of major symptoms and the role of inflammation. Clin. Infect. Dis. 2019;71:1749&#x2013;1755. doi: 10.1093/cid/ciz1062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz1062</ArticleId><ArticleId IdType="pmc">PMC7755089</ArticleId><ArticleId IdType="pubmed">31693114</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini G.A. Marburg virus disease. Postgrad. Med. J. 1973;49:542&#x2013;546. doi: 10.1136/pgmj.49.574.542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.49.574.542</ArticleId><ArticleId IdType="pmc">PMC2495590</ArticleId><ArticleId IdType="pubmed">4207635</ArticleId></ArticleIdList></Reference><Reference><Citation>Shifflett K., Marzi A. Marburg virus pathogenesis&#x2014;Differences and similarities in humans and animal models. Virol. J. 2019;16:1&#x2013;12. doi: 10.1186/s12985-019-1272-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-019-1272-z</ArticleId><ArticleId IdType="pmc">PMC6937685</ArticleId><ArticleId IdType="pubmed">31888676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezeomah C., Adoga A., Ihekweazu C., Paessler S., Cisneros I., Tomori O., Walker D. Sequelae of lassa fever: Postviral cerebellar ataxia. Open Forum Infect. Dis. 2019;6 doi: 10.1093/ofid/ofz512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz512</ArticleId><ArticleId IdType="pmc">PMC6923636</ArticleId><ArticleId IdType="pubmed">31879673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficenec S.C., Schieffelin J.S., Emmett S.D. A review of hearing loss associated with zika, Ebola, and Lassa fever. Am. J. Trop. Med. Hyg. 2019;101:484&#x2013;490. doi: 10.4269/ajtmh.18-0934.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.18-0934</ArticleId><ArticleId IdType="pmc">PMC6726950</ArticleId><ArticleId IdType="pubmed">31333155</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A.L., Grant D., Gbakie M., Kanneh L., Mustafa I., Bond N., Engel E., Schieffelin J., Vandy M.J., Yeh S., et al. Ophthalmic manifestations and vision impairment in Lassa fever survivors. PLoS ONE. 2020;15:e0243766. doi: 10.1371/journal.pone.0243766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243766</ArticleId><ArticleId IdType="pmc">PMC7728206</ArticleId><ArticleId IdType="pubmed">33301526</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T., B&#xf8;nnelykke K., Elenius V., Feleszko W. Role of viruses in asthma. Semin. Immunopathol. 2020;42:61&#x2013;74. doi: 10.1007/s00281-020-00781-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-020-00781-5</ArticleId><ArticleId IdType="pmc">PMC7066101</ArticleId><ArticleId IdType="pubmed">31989228</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf8;nnelykke K., Vissing N.H., Sevelsted A., Johnston S.L., Bisgaard H. Association between respiratory infections in early life and later asthma is independent of virus type. J. Allergy Clin. Immunol. 2015;136:81.e4&#x2013;86.e4. doi: 10.1016/j.jaci.2015.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.02.024</ArticleId><ArticleId IdType="pmc">PMC7112259</ArticleId><ArticleId IdType="pubmed">25910716</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F., Smith G.J.D., Fouchier R., Peiris J.S.M., Kedzierska K., Doherty P.C., Palese P., Shaw M.L., Treanor J., Webster R.G., et al. Influenza. Nat. Rev. Dis. Prim. 2018;4:3. doi: 10.1038/s41572-018-0002-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-018-0002-y</ArticleId><ArticleId IdType="pmc">PMC7097467</ArticleId><ArticleId IdType="pubmed">29955068</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauroux B., Sim&#xf5;es E.A.F., Checchia P.A., Paes B., Figueras-Aloy J., Manzoni P., Bont L., Carbonell-Estrany X. The burden and long-term respiratory morbidity associated with respiratory syncytial virus infection in early childhood. Infect. Dis. Ther. 2017;6:173&#x2013;197. doi: 10.1007/s40121-017-0151-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-017-0151-4</ArticleId><ArticleId IdType="pmc">PMC5446364</ArticleId><ArticleId IdType="pubmed">28357706</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi T., Ooi Y., Zaw E.M., Utjesanovic N., Campbell H., Cunningham S., Bont L., Nair H., Zhang S., Li Y., et al. Association between respiratory syncytial virus-associated acute lower respiratory infection in early life and recurrent wheeze and asthma in later childhood. J. Infect. Dis. 2019;222:S628&#x2013;S633. doi: 10.1093/infdis/jiz311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz311</ArticleId><ArticleId IdType="pubmed">31370064</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza I.N.O., Barros-Arag&#xe3;o F.G.Q., Frost P.S., Figueiredo C.P., Clarke J.R. Late neurological consequences of zika virus infection: Risk factors and pharmaceutical approaches. Pharmaceuticals. 2019;12:60. doi: 10.3390/ph12020060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph12020060</ArticleId><ArticleId IdType="pmc">PMC6631207</ArticleId><ArticleId IdType="pubmed">30999590</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppolu V., Raju T.S. Zika virus outbreak: A review of neurological complications, diagnosis, and treatment options. J. Neurovirol. 2018;24:255&#x2013;272. doi: 10.1007/s13365-018-0614-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-018-0614-8</ArticleId><ArticleId IdType="pubmed">29441490</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonhard S.E., Bresani-Salvi C.C., Batista J.D.L., Cunha S., Jacobs B.C., Ferreira M.L.B., Milit&#xe3;o de Albuquerque M.D.F.P. Guillain-Barr&#xe9; syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype. PLoS Negl. Trop. Dis. 2020;14:e0008264. doi: 10.1371/journal.pntd.0008264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008264</ArticleId><ArticleId IdType="pmc">PMC7205322</ArticleId><ArticleId IdType="pubmed">32339199</ArticleId></ArticleIdList></Reference><Reference><Citation>Grijalva I., Grajales-Mu&#xf1;iz C., Gonz&#xe1;lez-Bonilla C., Borja-Aburto V.H., Paredes-Cruz M., Guerrero-Cantera J., Gonz&#xe1;lez-Ibarra J., Vallejos-Par&#xe1;s A., Rojas-Mendoza T., Santacruz-Tinoco C.E., et al. Zika and dengue but not chikungunya are associated with Guillain-Barr&#xe9; syndrome in Mexico: A case-control study. PLoS Negl. Trop. Dis. 2020;14:e0008032. doi: 10.1371/journal.pntd.0008032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008032</ArticleId><ArticleId IdType="pmc">PMC7775118</ArticleId><ArticleId IdType="pubmed">33332366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira M.L.B., Albuquerque M.D.F.P.M.D., de Brito C.A.A., Fran&#xe7;a R.F.D.O., Moreira J.P., Machado M.D.M., Melo R.D.P., Medialdea-Carrera R., Mesquita S.D., Santos M.L., et al. Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: A prospective observational study. Lancet Neurol. 2020;19:826&#x2013;839. doi: 10.1016/S1474-4422(20)30232-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30232-5</ArticleId><ArticleId IdType="pmc">PMC7494308</ArticleId><ArticleId IdType="pubmed">32949543</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo N., Waggoner J., Rodriguez M., Rivera L., Landivar J., Pinsky B., Zambrano H. Zika virus, chikungunya virus, and dengue virus in cerebrospinal fluid from adults with neurological manifestations, Guayaquil, Ecuador. Front. Microbiol. 2017;8:42. doi: 10.3389/fmicb.2017.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.00042</ArticleId><ArticleId IdType="pmc">PMC5258761</ArticleId><ArticleId IdType="pubmed">28174559</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira L.D.A.S., Nogueira N.G.A., Nascentes G.A.N. Prospective study of patients with persistent symptoms of dengue in Brazil. Rev. Inst. Med. Trop. S&#xe3;o Paulo. 2017;59:e65. doi: 10.1590/s1678-9946201759065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1678-9946201759065</ArticleId><ArticleId IdType="pmc">PMC5587034</ArticleId><ArticleId IdType="pubmed">28876417</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G.-H., Ning Z.-J., Liu Y.-M., Li X.-H. Neurological manifestations of dengue infection. Front. Cell. Infect. Microbiol. 2017;7:449. doi: 10.3389/fcimb.2017.00449.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00449</ArticleId><ArticleId IdType="pmc">PMC5660970</ArticleId><ArticleId IdType="pubmed">29119088</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a G., Gonz&#xe1;lez N., P&#xe9;rez A.B., Sierra B., Aguirre E., Rizo D., Izquierdo A., S&#xe1;nchez L., D&#xed;az D., Lezcay M., et al. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int. J. Infect. Dis. 2011;15:e38&#x2013;e43. doi: 10.1016/j.ijid.2010.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.09.008</ArticleId><ArticleId IdType="pubmed">21112804</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H., Sander B., Nelder M.P. Long-term sequelae of West Nile virus-related illness: A systematic review. Lancet. 2015;15 doi: 10.1016/S1473-3099(15)00134-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00134-6</ArticleId><ArticleId IdType="pubmed">26163373</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray K., Walker C., Herrington E., Lewis J.A., McCormick J., Beasley D.W.C., Tesh R.B., Fisher-Hoch S. Persistent infection with West Nile virus years after initial infection. J. Infect. Dis. 2010;201:2&#x2013;4. doi: 10.1086/648731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/648731</ArticleId><ArticleId IdType="pmc">PMC2791189</ArticleId><ArticleId IdType="pubmed">19961306</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M.N., Hasbun R., Murray K.O. Persistence of West Nile virus. Microbes Infect. 2015;17:163&#x2013;168. doi: 10.1016/j.micinf.2014.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2014.12.003</ArticleId><ArticleId IdType="pubmed">25499188</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittor A.Y., Long M., Chakrabarty P., Aycock L., Kollu V., DeKosky S.T. West Nile virus-induced neurologic sequelae&#x2014;Relationship to neurodegenerative cascades and dementias. Curr. Trop. Med. Rep. 2020;7:25&#x2013;36. doi: 10.1007/s40475-020-00200-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40475-020-00200-7</ArticleId><ArticleId IdType="pmc">PMC7409821</ArticleId><ArticleId IdType="pubmed">32775145</ArticleId></ArticleIdList></Reference><Reference><Citation>Haglund M., G&#xfc;nther G. Tick-borne encephalitis&#x2014;Pathogenesis, clinical course and long-term follow-up. Vaccine. 2003;21:S11&#x2013;S18. doi: 10.1016/S0264-410X(02)00811-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(02)00811-3</ArticleId><ArticleId IdType="pubmed">12628810</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Dung N.M., Kneen R., Gainsborough M., Vaughn D.W., Khanh V.T. Neurological aspects of tropical disease: Japanese encephalitis. J. Neurol. Neurosurg. Psychiatry. 2000;68:405&#x2013;415. doi: 10.1136/jnnp.68.4.405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.68.4.405</ArticleId><ArticleId IdType="pmc">PMC1736874</ArticleId><ArticleId IdType="pubmed">10727474</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhrbier A. Rheumatic manifestations of chikungunya: Emerging concepts and interventions. Nat. Rev. Rheumatol. 2019;15:597&#x2013;611. doi: 10.1038/s41584-019-0276-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-019-0276-9</ArticleId><ArticleId IdType="pubmed">31481759</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta R., Gerardin P., De Brito C.A.A., Soares C.N., Ferreira M.L.B., Solomon T. The neurological complications of chikungunya virus: A systematic review. Rev. Med. Virol. 2018;28:e1978. doi: 10.1002/rmv.1978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1978</ArticleId><ArticleId IdType="pmc">PMC5969245</ArticleId><ArticleId IdType="pubmed">29671914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronca S.E., Dineley K.T., Paessler S. Neurological sequelae resulting from encephalitic alphavirus infection. Front. Microbiol. 2016;7:959. doi: 10.3389/fmicb.2016.00959.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00959</ArticleId><ArticleId IdType="pmc">PMC4913092</ArticleId><ArticleId IdType="pubmed">27379085</ArticleId></ArticleIdList></Reference><Reference><Citation>Selden S.M., Cameron S. Changing epidemiology of Ross River virus disease in South Australia. Med. J. Aust. 1996;165:313&#x2013;317. doi: 10.5694/j.1326-5377.1996.tb124989.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.1996.tb124989.x</ArticleId><ArticleId IdType="pubmed">8862330</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter M.C., Baxter V.K., Mathey R.W., Alt J., Rojas C., Griffin D.E., Slusher B.S. Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine. J. Neurovirol. 2015;21:159&#x2013;173. doi: 10.1007/s13365-015-0314-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-015-0314-6</ArticleId><ArticleId IdType="pmc">PMC4375032</ArticleId><ArticleId IdType="pubmed">25645378</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.-Y., Lin H.-Y., Gau S.S.-F., Lu C.-Y., Hsia S.-H., Huang Y.-C., Huang L.-M., Lin T.-Y. Enterovirus A71 neurologic complications and long-term sequelae. J. Biomed. Sci. 2019;26:1&#x2013;6. doi: 10.1186/s12929-019-0552-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0552-7</ArticleId><ArticleId IdType="pmc">PMC6688366</ArticleId><ArticleId IdType="pubmed">31395054</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L., Cheng Y., Li Y., Shang Q., Huang J., Ma C., Fang S., Long L., Zhou C., Chen Z., et al. Long-term neurodevelopment outcomes of hand, foot and mouth disease inpatients infected with EV-A71 or CV-A16, a retrospective cohort study. Emerg. Microbes Infect. 2021;10:1&#x2013;37. doi: 10.1080/22221751.2021.1901612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1901612</ArticleId><ArticleId IdType="pmc">PMC8009121</ArticleId><ArticleId IdType="pubmed">33691598</ArticleId></ArticleIdList></Reference><Reference><Citation>Aw-Yong K.L., NikNadia N.M.N., Tan C.W., Sam I., Chan Y.F. Immune responses against enterovirus A71 infection: Implications for vaccine success. Rev. Med. Virol. 2019;29:e2073. doi: 10.1002/rmv.2073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2073</ArticleId><ArticleId IdType="pubmed">31369184</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee H.K., Zainol M.I., Sam I.-C., Chan Y.F. Recent advances in the understanding of enterovirus A71 infection: A focus on neuropathogenesis. Expert Rev. Anti-Infect. Ther. 2021;19:733&#x2013;747. doi: 10.1080/14787210.2021.1851194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2021.1851194</ArticleId><ArticleId IdType="pubmed">33183118</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojan D.A., Cashman N.R. Post-poliomyelitis syndrome. Muscle Nerve. 2004;31:6&#x2013;19. doi: 10.1002/mus.20259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20259</ArticleId><ArticleId IdType="pubmed">15599928</ArticleId></ArticleIdList></Reference><Reference><Citation>Baj A., Monaco S., Zanusso G., Dall&#x2019;Ora E., Bertolasi L., Toniolo A. Virology of the post-polio syndrome. Futur. Virol. 2007;2:183&#x2013;192. doi: 10.2217/17460794.2.2.183.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/17460794.2.2.183</ArticleId></ArticleIdList></Reference><Reference><Citation>Farbu E., Rekand T., Tysnes O.-B., Aarli J., Gilhus N., Vedeler C. GM1 antibodies in post-polio syndrome and previous paralytic polio. J. Neuroimmunol. 2003;139:141&#x2013;144. doi: 10.1016/S0165-5728(03)00123-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(03)00123-1</ArticleId><ArticleId IdType="pubmed">12799031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg A.H., Gale M.J., Rose L.M., Clark E.A. T-cell alterations in late postpoliomyelitis. Arch. Neurol. 1989;46:497&#x2013;501. doi: 10.1001/archneur.1989.00520410031018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520410031018</ArticleId><ArticleId IdType="pubmed">2785378</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolwijk-Sw&#xfc;ste J.M., Beelen A., Lankhorst G.J., Nollet F. The course of functional status and muscle strength in patients with late-onset sequelae of poliomyelitis: A systematic review. Arch. Phys. Med. Rehabil. 2005;86:1693&#x2013;1701. doi: 10.1016/j.apmr.2004.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2004.12.022</ArticleId><ArticleId IdType="pubmed">16084828</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller J.A., Gro&#xdf; R., Conzelmann C., Kr&#xfc;ger J., Merle U., Steinhart J., Weil T., Koepke L., Bozzo C.P., Read C., et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat. Metab. 2021;3:149&#x2013;165. doi: 10.1038/s42255-021-00347-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00347-1</ArticleId><ArticleId IdType="pubmed">33536639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S., Bae J.H., Kwon H.-S., Nauck M.A. COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat. Rev. Endocrinol. 2020;17:11&#x2013;30. doi: 10.1038/s41574-020-00435-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00435-4</ArticleId><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.-T., Lidsky P.V., Xiao Y., Lee I.T., Cheng R., Nakayama T., Jiang S., Demeter J., Bevacqua R.J., Chang C.A., et al. SARS-CoV-2 infects human pancreatic &#x3b2; cells and elicits &#x3b2; cell impairment. Cell Metab. 2021;33:1565.e5&#x2013;1576.e5. doi: 10.1016/j.cmet.2021.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Di Cristanziano V., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021;27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Licciardi F., Pruccoli G., Denina M., Parodi E., Taglietto M., Rosati S., Montin D. SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: A novel COVID phenotype in children. Pediatrics. 2020;146:e20201711. doi: 10.1542/peds.2020-1711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-1711</ArticleId><ArticleId IdType="pubmed">32439816</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M.H.-B., Wing Y.-K., Yu M.W.-M., Leung C.-M., Ma R.C.W., Kong A.P.S., So W., Fong S.Y.-Y., Lam S.-P. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan O. Long-Term sequelae following previous coronavirus epidemics. Clin. Med. 2021;21:e68&#x2013;e70. doi: 10.7861/clinmed.2020-0204.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0204</ArticleId><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C. A unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Recognitions from the finding of autoantibodies against &#xdf;2-adrenergic receptors. Autoimmun. Rev. 2020;19:102527. doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType="pubmed">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemming-Harlo M., L&#xe4;hdeaho M.-L., M&#xe4;ki M., Vesikari T. Rotavirus vaccination does not increase type 1 diabetes and may decrease celiac disease in children and adolescents. Pediatr. Infect. Dis. J. 2019;38:539&#x2013;541. doi: 10.1097/INF.0000000000002281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002281</ArticleId><ArticleId IdType="pubmed">30986791</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrett K., Jachno K., Nolan T.M., Harrison L.C. Association of rotavirus vaccination with the incidence of type 1 diabetes in children. JAMA Pediatr. 2019;173:280&#x2013;282. doi: 10.1001/jamapediatrics.2018.4578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2018.4578</ArticleId><ArticleId IdType="pmc">PMC6439878</ArticleId><ArticleId IdType="pubmed">30667473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishizaki Y., Takemoto M., Kira R., Kusuhara K., Torisu H., Sakai Y., Sanefuji M., Yukaya N., Hara T. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. J. Neurovirol. 2008;14:486&#x2013;491. doi: 10.1080/13550280802298120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280802298120</ArticleId><ArticleId IdType="pubmed">19016379</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Coffin K.M., Johnston S.C., Babka A.M., Bell T.M., Long S.Y., Honko A.N., Kuhn J.H., Zeng X. Nipah virus persists in the brains of nonhuman primate survivors. JCI Insight. 2019;4 doi: 10.1172/jci.insight.129629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.129629</ArticleId><ArticleId IdType="pmc">PMC6675545</ArticleId><ArticleId IdType="pubmed">31341108</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  Ebola Virus Disease.  [(accessed on 12 August 2021)];2021  Available online:  https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease.</Citation></Reference><Reference><Citation>Reisler R.B., Zeng X., Schellhase C.W., Bearss J.J., Warren T.K., Trefry J.C., Christopher G.W., Kortepeter M.G., Bavari S., Cardile A.P. Ebola virus causes intestinal tract architectural disruption and bacterial invasion in non-human primates. Viruses. 2018;10:513. doi: 10.3390/v10100513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10100513</ArticleId><ArticleId IdType="pmc">PMC6213817</ArticleId><ArticleId IdType="pubmed">30241284</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman K.A., Wilkinson E.R., Zeng X., Cardile A.P., Facemire P.R., Bell T.M., Bearss J.J., Shaia C., Schmaljohn C.S. Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following Lassa virus exposure in cynomolgus macaques. mBio. 2018;9:e01896-18. doi: 10.1128/mBio.01896-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01896-18</ArticleId><ArticleId IdType="pmc">PMC6212830</ArticleId><ArticleId IdType="pubmed">30377282</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeler S.P., Agapov E.V., Hinojosa M.E., Letvin A.N., Wu K., Holtzman M.J. Influenza a virus infection causes chronic lung disease linked to sites of active viral RNA remnants. J. Immunol. 2018;201:2354&#x2013;2368. doi: 10.4049/jimmunol.1800671.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800671</ArticleId><ArticleId IdType="pmc">PMC6179922</ArticleId><ArticleId IdType="pubmed">30209189</ArticleId></ArticleIdList></Reference><Reference><Citation>Driscoll A.J., Arshad S.H., Bont L., Brunwasser S.M., Cherian T., Englund J.A., Fell D.B., Hammitt L.L., Hartert T.V., Innis B.L., et al. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting. Vaccine. 2020;38:2435&#x2013;2448. doi: 10.1016/j.vaccine.2020.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.01.020</ArticleId><ArticleId IdType="pmc">PMC7049900</ArticleId><ArticleId IdType="pubmed">31974017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehners N., Tabatabai J., Prifert C., Wedde M., Puthenparambil J., Weissbrich B., Biere B., Schweiger B., Egerer G., Schnitzler P. Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders. PLoS ONE. 2016;11:e0148258. doi: 10.1371/journal.pone.0148258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0148258</ArticleId><ArticleId IdType="pmc">PMC4750950</ArticleId><ArticleId IdType="pubmed">26866481</ArticleId></ArticleIdList></Reference><Reference><Citation>Rane C.K., Jackson S.R., Pastore C.F., Zhao G., Weiner A.I., Patel N.N., Herbert D.R., Cohen N.A., Vaughan A.E. Development of solitary chemosensory cells in the distal lung after severe influenza injury. Am. J. Physiol. Cell. Mol. Physiol. 2019;316:L1141&#x2013;L1149. doi: 10.1152/ajplung.00032.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00032.2019</ArticleId><ArticleId IdType="pmc">PMC6620670</ArticleId><ArticleId IdType="pubmed">30908939</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton N.S., Langlois R.A., Sachs D., Lim J.K., Palese P., Tenoever B.R. Long-term survival of influenza virus infected club cells drives immunopathology. J. Exp. Med. 2014;211:1707&#x2013;1714. doi: 10.1084/jem.20140488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20140488</ArticleId><ArticleId IdType="pmc">PMC4144728</ArticleId><ArticleId IdType="pubmed">25135297</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia G.L., Valenzuela A., Manzoni T., Vaughan A.E., L&#xf3;pez C.B. Distinct chronic post-viral lung diseases upon infection with influenza or parainfluenza viruses differentially impact superinfection outcome. Am. J. Pathol. 2020;190:543&#x2013;553. doi: 10.1016/j.ajpath.2019.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2019.11.003</ArticleId><ArticleId IdType="pmc">PMC7073775</ArticleId><ArticleId IdType="pubmed">31866346</ArticleId></ArticleIdList></Reference><Reference><Citation>Willison H.J., Jacobs B.C., van Doorn P. Guillain-Barr&#xe9; syndrome. Lancet. 2016;388:717&#x2013;727. doi: 10.1016/S0140-6736(16)00339-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00339-1</ArticleId><ArticleId IdType="pubmed">26948435</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Filho J.L., Oliveira L.G., Monteiro L., Parise P.L., Zanluqui N.G., Polonio C.M., Freitas C.L., Toledo-Teixeira D.A., Souza W.M., Bittencourt N., et al. Gas6 drives zika virus-induced neurological complications in humans and congenital syndrome in immunocompetent mice. bioRxiv. 2021 doi: 10.1101/2021.01.27.428402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.428402</ArticleId><ArticleId IdType="pubmed">34390806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S., Gething P., Brady O., Messina J.P., Farlow A.W., Moyes C., Drake J., Brownstein J.S., Hoen A.G., Sankoh O., et al. The global distribution and burden of dengue. Nat. Cell Biol. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulton C.D., Beasley D.W., Bente D.A., Dineley K.T. Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent models. Brain Behav. Immun. Health. 2020;7:100105. doi: 10.1016/j.bbih.2020.100105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100105</ArticleId><ArticleId IdType="pmc">PMC8474605</ArticleId><ArticleId IdType="pubmed">34589866</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber C., Soung A., Vollmer L.L., Kanmogne M., Last A., Brown J., Klein R.S. T cells promote microglia-mediated synaptic elimination and cognitive dysfunction during recovery from neuropathogenic flaviviruses. Nat. Neurosci. 2019;22:1276&#x2013;1288. doi: 10.1038/s41593-019-0427-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0427-y</ArticleId><ArticleId IdType="pmc">PMC6822175</ArticleId><ArticleId IdType="pubmed">31235930</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Aalst M., Nelen C.M., Goorhuis A., Stijnis C., Grobusch M.P. Long-Term Sequelae of Chikungunya Virus Disease: A Systematic Review. Elsevier; Amsterdam, The Netherlands: 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28163198</ArticleId></ArticleIdList></Reference><Reference><Citation>Poo Y.S., Rudd P.A., Gardner J., Wilson J.A.C., Larcher T., Colle M.-A., Le T.T., Nakaya H., Warrilow D., Allcock R., et al. Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection. PLoS Negl. Trop. Dis. 2014;8:e3354. doi: 10.1371/journal.pntd.0003354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003354</ArticleId><ArticleId IdType="pmc">PMC4256279</ArticleId><ArticleId IdType="pubmed">25474568</ArticleId></ArticleIdList></Reference><Reference><Citation>Bantle C.M., Phillips A.T., Smeyne R.J., Rocha S.M., Olson K.E., Tjalkens R.B. Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation. NPJ Parkinson&#x2019;s Dis. 2019;5:1&#x2013;15. doi: 10.1038/s41531-019-0090-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-019-0090-8</ArticleId><ArticleId IdType="pmc">PMC6744428</ArticleId><ArticleId IdType="pubmed">31531390</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzum M., Ruppert V., K&#xfc;ytz B., Jomaa H., Nakamura I., Maisch B. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J. Mol. Cell. Cardiol. 1994;26:907&#x2013;913. doi: 10.1006/jmcc.1994.1108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmcc.1994.1108</ArticleId><ArticleId IdType="pubmed">7966359</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K., Orthopoulos G., Vakakis E., Ahmed M.A.E., Golenbock D.T., Lepper P.M., Triantafilou M. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly toll-like receptor (TLR) 8-dependent. Cell. Microbiol. 2005;7:1117&#x2013;1126. doi: 10.1111/j.1462-5822.2005.00537.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2005.00537.x</ArticleId><ArticleId IdType="pubmed">16008579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bickerstaffe A., Beelen A., Lutter R., Nollet F. Elevated plasma inflammatory mediators in post-polio syndrome: No association with long-term functional decline. J. Neuroimmunol. 2015;289:162&#x2013;167. doi: 10.1016/j.jneuroim.2015.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2015.10.019</ArticleId><ArticleId IdType="pubmed">26616886</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatematsu M., Nishikawa F., Seya T., Matsumoto M. Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA. Nat. Commun. 2013;4:1833. doi: 10.1038/ncomms2857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2857</ArticleId><ArticleId IdType="pubmed">23673618</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho T., Krammer F., Iwasaki A. The first 12 months of COVID-19: A timeline of immunological insights. Nat. Rev. Immunol. 2021;21:245&#x2013;256. doi: 10.1038/s41577-021-00522-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00522-1</ArticleId><ArticleId IdType="pmc">PMC7958099</ArticleId><ArticleId IdType="pubmed">33723416</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbeke L., Van Mol P., Van Herck Y., De Smet F., Humblet-Baron S., Martinod K., Antoranz A., Arijs I., Boeckx B., Bosisio F.M., et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat. Commun. 2021;12:4117. doi: 10.1038/s41467-021-24360-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24360-w</ArticleId><ArticleId IdType="pmc">PMC8257697</ArticleId><ArticleId IdType="pubmed">34226537</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of immune activation and inflammation in individuals with post-acute sequelae of SARS-CoV-2 infection. medRxiv. 2021 doi: 10.1101/2021.07.09.21260287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.09.21260287</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nat. Cell Biol. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans L.J., Khan M., Yoo S.-J., Zapiec B., Van Gerven L., Van Slambrouck J., Vanstapel A., Van Raemdonck D., Vos R., Wauters E., et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir. Med. 2021 doi: 10.1016/S2213-2600(21)00240-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00240-X</ArticleId><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramlall V., Thangaraj P.M., Meydan C., Foox J., Butler D., Kim J., May B., De Freitas J.K., Glicksberg B.S., Mason C.E., et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat. Med. 2020;26:1609&#x2013;1615. doi: 10.1038/s41591-020-1021-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1021-2</ArticleId><ArticleId IdType="pmc">PMC7809634</ArticleId><ArticleId IdType="pubmed">32747830</ArticleId></ArticleIdList></Reference><Reference><Citation>Java A., Apicelli A.J., Liszewski M.K., Coler-Reilly A., Atkinson J.P., Kim A.H., Kulkarni H.S. The complement system in COVID-19: Friend and foe? JCI Insight. 2020;5 doi: 10.1172/jci.insight.140711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140711</ArticleId><ArticleId IdType="pmc">PMC7455060</ArticleId><ArticleId IdType="pubmed">32554923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., Chen J., Ogishi M., Sabli I.K.D., Hodeib S., Korol C., et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570. doi: 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhadelia N., Belkina A.C., Olson A., Winters T., Urick P., Lin N., Rifkin I., Kataria Y., Yuen R.R., Sagar M., et al. Distinct autoimmune antibody signatures between hospitalized acute COVID-19 patients, SARS-CoV-2 convalescent individuals, and unexposed pre-pandemic controls. medRxiv. 2021 doi: 10.1101/2021.01.21.21249176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.21.21249176</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Estes S.K., Ali R.A., Gandhi A.A., Yalavarthi S., Shi H., Sule G., Gockman K., Madison J.A., Zuo M., et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 2020;12:eabd3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett J.M., Reeves G., Billman G.E., Sturmberg J.P. Inflammation-nature&#x2019;s way to efficiently respond to all types of challenges: Implications for understanding and managing &#x201c;the epidemic&#x201d; of chronic diseases. Front. Med. 2018;5:316. doi: 10.3389/fmed.2018.00316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2018.00316</ArticleId><ArticleId IdType="pmc">PMC6277637</ArticleId><ArticleId IdType="pubmed">30538987</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D., Campisi J., Verdin E., Carrera-Bastos P., Targ S., Franceschi C., Ferrucci L., Gilroy D.W., Fasano A., Miller G.W., et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 2019;25:1822&#x2013;1832. doi: 10.1038/s41591-019-0675-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0675-0</ArticleId><ArticleId IdType="pmc">PMC7147972</ArticleId><ArticleId IdType="pubmed">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence T., Gilroy D. Chronic inflammation: A failure of resolution? Int. J. Exp. Pathol. 2006;88:85&#x2013;94. doi: 10.1111/j.1365-2613.2006.00507.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2613.2006.00507.x</ArticleId><ArticleId IdType="pmc">PMC2517296</ArticleId><ArticleId IdType="pubmed">17408451</ArticleId></ArticleIdList></Reference><Reference><Citation>Boasso A., Shearer G.M. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin. Immunol. 2008;126:235&#x2013;242. doi: 10.1016/j.clim.2007.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2007.08.015</ArticleId><ArticleId IdType="pmc">PMC2275778</ArticleId><ArticleId IdType="pubmed">17916442</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A. Innate immune recognition of HIV-1. Immunity. 2012;37:389&#x2013;398. doi: 10.1016/j.immuni.2012.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.08.011</ArticleId><ArticleId IdType="pmc">PMC3578946</ArticleId><ArticleId IdType="pubmed">22999945</ArticleId></ArticleIdList></Reference><Reference><Citation>Siliciano R.F., Greene W.C. HIV latency. Harb. Perspect. Med. 2011;1:a007096. doi: 10.1101/cshperspect.a007096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a007096</ArticleId><ArticleId IdType="pmc">PMC3234450</ArticleId><ArticleId IdType="pubmed">22229121</ArticleId></ArticleIdList></Reference><Reference><Citation>Cary D.C., Fujinaga K., Peterlin B.M. Molecular mechanisms of HIV latency. J. Clin. Investig. 2016;126:448&#x2013;454. doi: 10.1172/JCI80565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI80565</ArticleId><ArticleId IdType="pmc">PMC4731164</ArticleId><ArticleId IdType="pubmed">26731470</ArticleId></ArticleIdList></Reference><Reference><Citation>Me&#xe5;s H.Z., Haug M., Beckwith M.S., Louet C., Ryan L., Hu Z., Landskron J., Nordb&#xf8; S.A., Tasken K., Yin H., et al. Sensing of HIV-1 by TLR8 activates human T cells and reverses latency. Nat. Commun. 2020;11:147. doi: 10.1038/s41467-019-13837-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13837-4</ArticleId><ArticleId IdType="pmc">PMC6952430</ArticleId><ArticleId IdType="pubmed">31919342</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson A., Coote C., Snyder-Cappione J., Lin N., Sagar M. HIV-1 transcription but not intact provirus levels are associated with systemic inflammation. J. Infect. Dis. 2021;223:1934&#x2013;1942. doi: 10.1093/infdis/jiaa657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa657</ArticleId><ArticleId IdType="pmc">PMC8176637</ArticleId><ArticleId IdType="pubmed">33075121</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Sydow M., S&#xf6;nnerborg A., Gaines H. Stranneg&#xe5;rd, Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res. Hum. Retrovir. 1991;7:375&#x2013;380. doi: 10.1089/aid.1991.7.375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.1991.7.375</ArticleId><ArticleId IdType="pubmed">1906289</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks S.G., Tracy R., Douek D.C. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39:633&#x2013;645. doi: 10.1016/j.immuni.2013.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.10.001</ArticleId><ArticleId IdType="pmc">PMC4012895</ArticleId><ArticleId IdType="pubmed">24138880</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenchley J.M., Price D., Schacker T.W., Asher T., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006;12:1365&#x2013;1371. doi: 10.1038/nm1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1511</ArticleId><ArticleId IdType="pubmed">17115046</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.Y., Alden S.L., Funderburg N., Fu P., Levine A.D. Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals. PLoS Pathog. 2014;10:e1004198. doi: 10.1371/journal.ppat.1004198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004198</ArticleId><ArticleId IdType="pmc">PMC4072797</ArticleId><ArticleId IdType="pubmed">24968145</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazli A., Chan O., Dobson-Belaire W.N., Ouellet M., Tremblay M.J., Gray-Owen S.D., Arsenault A.L., Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010;6:e1000852. doi: 10.1371/journal.ppat.1000852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000852</ArticleId><ArticleId IdType="pmc">PMC2851733</ArticleId><ArticleId IdType="pubmed">20386714</ArticleId></ArticleIdList></Reference><Reference><Citation>Crakes K.R., Jiang G. Gut microbiome alterations during HIV/SIV infection: Implications for HIV cure. Front. Microbiol. 2019;10:1104. doi: 10.3389/fmicb.2019.01104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01104</ArticleId><ArticleId IdType="pmc">PMC6539195</ArticleId><ArticleId IdType="pubmed">31191468</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., Kobold S. Inflammation: A common contributor to cancer, aging, and cardiovascular diseases, expanding the concept of cardio-oncology. Cardiovasc. Res. 2019;115:824&#x2013;829. doi: 10.1093/cvr/cvz058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvz058</ArticleId><ArticleId IdType="pmc">PMC6452304</ArticleId><ArticleId IdType="pubmed">30830168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata H.J., Shaw A.C. Aging of the human innate immune system in HIV infection. Curr. Opin. Immunol. 2014;29:127&#x2013;136. doi: 10.1016/j.coi.2014.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2014.06.007</ArticleId><ArticleId IdType="pmc">PMC4145838</ArticleId><ArticleId IdType="pubmed">24997358</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedaghat A.R., German J., Teslovich T.M., Cofrancesco J., Jie C.C., Talbot C.C., Siliciano R.F. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: Type I interferon-mediated disruption of T-cell dynamics. J. Virol. 2008;82:1870&#x2013;1883. doi: 10.1128/JVI.02228-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02228-07</ArticleId><ArticleId IdType="pmc">PMC2258719</ArticleId><ArticleId IdType="pubmed">18077723</ArticleId></ArticleIdList></Reference><Reference><Citation>Rempel H., Sun B., Calosing C., Pillai S.K., Pulliam L. Interferon-&#x3b1; drives monocyte gene expression in chronic unsuppressed HIV-1 infection. AIDS. 2010;24:1415&#x2013;1423. doi: 10.1097/QAD.0b013e32833ac623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e32833ac623</ArticleId><ArticleId IdType="pmc">PMC2991092</ArticleId><ArticleId IdType="pubmed">20495440</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez S., Tanaskovic S., Helbig K., Rajasuriar R., Kramski M., Murray J., Beard M., Purcell A., Lewin S.R., Price P., et al. CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells. J. Infect. Dis. 2011;204:1927&#x2013;1935. doi: 10.1093/infdis/jir659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir659</ArticleId><ArticleId IdType="pubmed">22006994</ArticleId></ArticleIdList></Reference><Reference><Citation>Megahed F.A.K., Zhou X., Sun P. The interactions between HBV and the innate immunity of hepatocytes. Viruses. 2020;12:285. doi: 10.3390/v12030285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12030285</ArticleId><ArticleId IdType="pmc">PMC7150781</ArticleId><ArticleId IdType="pubmed">32151000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Meng Z., Jiang M., Pei R., Trippler M., Broering R., Bucchi A., Sowa J.-P., Dittmer U., Yang D., et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology. 2008;49:1132&#x2013;1140. doi: 10.1002/hep.22751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.22751</ArticleId><ArticleId IdType="pubmed">19140219</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;sel M., Quasdorff M., Wiegmann K., Webb D., Zedler U., Broxtermann M., Tedjokusumo R., Esser K., Arzberger S., Kirschning C.J., et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology. 2009;50:1773&#x2013;1782. doi: 10.1002/hep.23226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23226</ArticleId><ArticleId IdType="pubmed">19937696</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieland S., Thimme R., Purcell R.H., Chisari F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA. 2004;101:6669&#x2013;6674. doi: 10.1073/pnas.0401771101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0401771101</ArticleId><ArticleId IdType="pmc">PMC404103</ArticleId><ArticleId IdType="pubmed">15100412</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehermann B., Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005;5:215&#x2013;229. doi: 10.1038/nri1573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1573</ArticleId><ArticleId IdType="pubmed">15738952</ArticleId></ArticleIdList></Reference><Reference><Citation>Venook A.P., Papandreou C., Furuse J., De Guevara L.L. The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective. Oncologist. 2010;15:5&#x2013;13. doi: 10.1634/theoncologist.2010-S4-05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2010-S4-05</ArticleId><ArticleId IdType="pubmed">21115576</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoletti A., Kennedy P.T. The immune tolerant phase of chronic HBV infection: New perspectives on an old concept. Cell. Mol. Immunol. 2014;12:258&#x2013;263. doi: 10.1038/cmi.2014.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2014.79</ArticleId><ArticleId IdType="pmc">PMC4654319</ArticleId><ArticleId IdType="pubmed">25176526</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Gong R., Mu Y., Chen Y., Zhu C., Sun Z., Chen M., Liu Y., Zhu Y., Wu J. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2. J. Immunol. 2011;187:4844&#x2013;4860. doi: 10.4049/jimmunol.1100998.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100998</ArticleId><ArticleId IdType="pubmed">21957142</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Tian Z. HBV-induced immune imbalance in the development of HCC. Front. Immunol. 2019;10:2048. doi: 10.3389/fimmu.2019.02048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02048</ArticleId><ArticleId IdType="pmc">PMC6718466</ArticleId><ArticleId IdType="pubmed">31507621</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmasova I.P., Yushchuk N.D., Mynbaev O., Alla N.R., Malova E., Shi Z., Gao C.-L. Immunopathogenesis of chronic hepatitis B. World J. Gastroenterol. 2014;20:14156&#x2013;14171. doi: 10.3748/wjg.v20.i39.14156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i39.14156</ArticleId><ArticleId IdType="pmc">PMC4202346</ArticleId><ArticleId IdType="pubmed">25339804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoletti A. Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003;38:4&#x2013;13. doi: 10.1053/jhep.2003.50310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jhep.2003.50310</ArticleId><ArticleId IdType="pubmed">12829979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieland S.F., Chisari F.V. Stealth and cunning: Hepatitis B and Hepatitis C viruses. J. Virol. 2005;79:9369&#x2013;9380. doi: 10.1128/JVI.79.15.9369-9380.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.15.9369-9380.2005</ArticleId><ArticleId IdType="pmc">PMC1181548</ArticleId><ArticleId IdType="pubmed">16014900</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanlandschoot P., Van Houtte F., Roobrouck A., Farhoudi A., Stelter F., Peterson D.L., G&#xf3;mez-Guti&#xe9;rrez J., Gavilanes F., Leroux-Roels G. LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. J. Gen. Virol. 2002;83:2279&#x2013;2289. doi: 10.1099/0022-1317-83-9-2279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-9-2279</ArticleId><ArticleId IdType="pubmed">12185283</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H., Tan G., Yang Y., Cui A., Li H., Li T., Wu Z., Yang M., Lv G., Chi X., et al. Hepatitis B virus-induced imbalance of inflammatory and antiviral signaling by differential phosphorylation of STAT1 in human monocytes. J. Immunol. 2019;202:2266&#x2013;2275. doi: 10.4049/jimmunol.1800848.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800848</ArticleId><ArticleId IdType="pubmed">30842274</ArticleId></ArticleIdList></Reference><Reference><Citation>Leboss&#xe9; F., Testoni B., Fresquet J., Facchetti F., Galmozzi E., Fournier M., Hervieu V., Berthillon P., Berby F., Bordes I., et al. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. J. Hepatol. 2016;66:897&#x2013;909. doi: 10.1016/j.jhep.2016.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2016.12.024</ArticleId><ArticleId IdType="pubmed">28043874</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcocci M.E., Napoletani G., Protto V., Kolesova O., Piacentini R., Puma D.D.L., Lomonte P., Grassi C., Palamara A.T., De Chiara G. Herpes simplex virus-1 in the brain: The dark side of a sneaky infection. Trends Microbiol. 2020;28:808&#x2013;820. doi: 10.1016/j.tim.2020.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.03.003</ArticleId><ArticleId IdType="pubmed">32386801</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw A.C., Goldstein D., Montgomery R. Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 2013;13:875&#x2013;887. doi: 10.1038/nri3547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3547</ArticleId><ArticleId IdType="pmc">PMC4096436</ArticleId><ArticleId IdType="pubmed">24157572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayed R. Infectious etiology and amyloidosis in Alzheimer&#x2019;s Disease: The puzzle continues. J. Biol. Chem. 2021;297:100936. doi: 10.1016/j.jbc.2021.100936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100936</ArticleId><ArticleId IdType="pmc">PMC8319577</ArticleId><ArticleId IdType="pubmed">34217702</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki R. Overwhelming evidence for a major role for herpes simplex virus type 1 (HSV1) in Alzheimer&#x2019;s Disease (AD), underwhelming evidence against. Vaccines. 2021;9:679. doi: 10.3390/vaccines9060679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9060679</ArticleId><ArticleId IdType="pmc">PMC8234998</ArticleId><ArticleId IdType="pubmed">34205498</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte L.F., Far&#xed;as M.A., &#xc1;lvarez D.M., Bueno S.M., Riedel C., Gonz&#xe1;lez P.A. Herpes simplex virus type 1 infection of the central nervous system: Insights into proposed interrelationships with neurodegenerative disorders. Front. Cell. Neurosci. 2019;13:46. doi: 10.3389/fncel.2019.00046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00046</ArticleId><ArticleId IdType="pmc">PMC6399123</ArticleId><ArticleId IdType="pubmed">30863282</ArticleId></ArticleIdList></Reference><Reference><Citation>Hait A.S., Olagnier D., Sancho-Shimizu V., Skipper K.A., Helleberg M., Larsen S.M., Bodda C., Moldovan L.I., Ren F., Andersen N.-S.B., et al. Defects in LC3B2 and ATG4A underlie HSV2 meningitis and reveal a critical role for autophagy in antiviral defense in humans. Sci. Immunol. 2020;5:eabc2691. doi: 10.1126/sciimmunol.abc2691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc2691</ArticleId><ArticleId IdType="pmc">PMC7611067</ArticleId><ArticleId IdType="pubmed">33310865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright W.F., Palisoc K., Baghli S. Mollaret meningitis. J. Neurol. Sci. 2019;396:148&#x2013;149. doi: 10.1016/j.jns.2018.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2018.11.018</ArticleId><ArticleId IdType="pubmed">30471634</ArticleId></ArticleIdList></Reference><Reference><Citation>Monk B.J., Tewari K.S. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol. Oncol. 2007;107:S6&#x2013;S13. doi: 10.1016/j.ygyno.2007.07.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygyno.2007.07.076</ArticleId><ArticleId IdType="pubmed">18499914</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121&#x2013;141. doi: 10.1016/j.cell.2014.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.03.011</ArticleId><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D., Liwinski T., Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30:492&#x2013;506. doi: 10.1038/s41422-020-0332-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0332-7</ArticleId><ArticleId IdType="pmc">PMC7264227</ArticleId><ArticleId IdType="pubmed">32433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y.-C., Yeh W.-C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42:145&#x2013;151. doi: 10.1016/j.cyto.2008.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2008.01.006</ArticleId><ArticleId IdType="pubmed">18304834</ArticleId></ArticleIdList></Reference><Reference><Citation>Man S.M. Inflammasomes in the gastrointestinal tract: Infection, cancer and gut microbiota homeostasis. Nat. Rev. Gastroenterol. Hepatol. 2018;15:721&#x2013;737. doi: 10.1038/s41575-018-0054-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-018-0054-1</ArticleId><ArticleId IdType="pmc">PMC7097092</ArticleId><ArticleId IdType="pubmed">30185915</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.R., Blumenschein W., Murphy E., Diveu C., Wiekowski M., Abbondanzo S., Lucian L., Geissler R., Brodie S., Kimball A., et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2&#x2013;dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 2006;203:2577&#x2013;2587. doi: 10.1084/jem.20060244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20060244</ArticleId><ArticleId IdType="pmc">PMC2118145</ArticleId><ArticleId IdType="pubmed">17074928</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold S., Becker C., Ridge K.M., Budinger G.S. Influenza virus-induced lung injury: Pathogenesis and implications for treatment. Eur. Respir. J. 2015;45:1463&#x2013;1478. doi: 10.1183/09031936.00186214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00186214</ArticleId><ArticleId IdType="pubmed">25792631</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates B.M., Staricha K.L., Koch C.M., Cheng Y., Shumaker D.K., Budinger G.R.S., Perlman H., Misharin A.V., Ridge K.M. Inflammatory monocytes drive influenza a virus-mediated lung injury in juvenile mice. J. Immunol. 2018;200:2391&#x2013;2404. doi: 10.4049/jimmunol.1701543.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701543</ArticleId><ArticleId IdType="pmc">PMC5860989</ArticleId><ArticleId IdType="pubmed">29445006</ArticleId></ArticleIdList></Reference><Reference><Citation>Enaud R., Prevel R., Ciarlo E., Beaufils F., Wie&#xeb;rs G., Guery B., Delhaes L. The gut-lung axis in health and respiratory diseases: A place for inter-organ and inter-kingdom crosstalks. Front. Cell. Infect. Microbiol. 2020;10:9. doi: 10.3389/fcimb.2020.00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00009</ArticleId><ArticleId IdType="pmc">PMC7042389</ArticleId><ArticleId IdType="pubmed">32140452</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo J.-K., Kim T.S., Hufford M.M., Braciale T.J. Viral infection of the lung: Host response and sequelae. J. Allergy Clin. Immunol. 2013;132:1263&#x2013;1276. doi: 10.1016/j.jaci.2013.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2013.06.006</ArticleId><ArticleId IdType="pmc">PMC3844062</ArticleId><ArticleId IdType="pubmed">23915713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojanovi&#x107; S.D., Fiedler J., Bauersachs J., Thum T., Sedding D.G. Senescence-induced inflammation: An important player and key therapeutic target in atherosclerosis. Eur. Hear. J. 2020;41:2983&#x2013;2996. doi: 10.1093/eurheartj/ehz919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz919</ArticleId><ArticleId IdType="pmc">PMC7453834</ArticleId><ArticleId IdType="pubmed">31898722</ArticleId></ArticleIdList></Reference><Reference><Citation>Camell C.D., Yousefzadeh M.J., Zhu Y., Prata L.G.P.L., Huggins M.A., Pierson M., Zhang L., O&#x2019;Kelly R.D., Pirtskhalava T., Xun P., et al. Senolytics reduce coronavirus-related mortality in old mice. Science. 2021;373:eabe4832. doi: 10.1126/science.abe4832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe4832</ArticleId><ArticleId IdType="pmc">PMC8607935</ArticleId><ArticleId IdType="pubmed">34103349</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin O., Alon U. Senescent cell accumulation mechanisms inferred from parabiosis. GeroScience. 2020;43:329&#x2013;341. doi: 10.1007/s11357-020-00286-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00286-x</ArticleId><ArticleId IdType="pmc">PMC8050176</ArticleId><ArticleId IdType="pubmed">33236264</ArticleId></ArticleIdList></Reference><Reference><Citation>Seoane R., Vidal S., Bouzaher Y.H., Motiam A., Rivas C. The interaction of viruses with the cellular senescence response. Biology. 2020;9:455. doi: 10.3390/biology9120455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology9120455</ArticleId><ArticleId IdType="pmc">PMC7764305</ArticleId><ArticleId IdType="pubmed">33317104</ArticleId></ArticleIdList></Reference><Reference><Citation>Solana R., Pawelec G., Tarazona R. Aging and innate immunity. Immunity. 2006;24:491&#x2013;494. doi: 10.1016/j.immuni.2006.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.05.003</ArticleId><ArticleId IdType="pubmed">16713963</ArticleId></ArticleIdList></Reference><Reference><Citation>Licastro F., Candore G., Lio D., Porcellini E., Colonna-Romano G., Franceschi C., Caruso C. Innate immunity and inflammation in ageing: A key for understanding age-related diseases. Immun. Ageing. 2005;2:8. doi: 10.1186/1742-4933-2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-2-8</ArticleId><ArticleId IdType="pmc">PMC1166571</ArticleId><ArticleId IdType="pubmed">15904534</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman C., Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia. 2021;13:1&#x2013;15. doi: 10.1186/s41479-021-00083-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41479-021-00083-w</ArticleId><ArticleId IdType="pmc">PMC8068564</ArticleId><ArticleId IdType="pubmed">33894790</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgin H.W. The virome in mammalian physiology and disease. Cell. 2014;157:142&#x2013;150. doi: 10.1016/j.cell.2014.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.02.032</ArticleId><ArticleId IdType="pmc">PMC3977141</ArticleId><ArticleId IdType="pubmed">24679532</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgin H.W., Wherry E.J., Ahmed R. Redefining chronic viral infection. Cell. 2009;138:30&#x2013;50. doi: 10.1016/j.cell.2009.06.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.06.036</ArticleId><ArticleId IdType="pubmed">19596234</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwani S., Khan M.A., SulimanAlmogbel M. Autoantibodies in Viral Infections. IntechOpen; London, UK: 2018.</Citation></Reference><Reference><Citation>Cusick M.F., Libbey J.E., Fujinami R.S. Molecular mimicry as a mechanism of autoimmune disease. Clin. Rev. Allergy Immunol. 2011;42:102&#x2013;111. doi: 10.1007/s12016-011-8294-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-011-8294-7</ArticleId><ArticleId IdType="pmc">PMC3266166</ArticleId><ArticleId IdType="pubmed">22095454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa C., Germain R.N. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: Endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J. Immunol. 1999;162:6552&#x2013;6561.</Citation><ArticleIdList><ArticleId IdType="pubmed">10352271</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella M., Engering A., Pinet V., Pieters J., Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nat. Cell Biol. 1997;388:782&#x2013;787. doi: 10.1038/42030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/42030</ArticleId><ArticleId IdType="pubmed">9285591</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza K.M., Chan S.M., Suri R., Nguyen L.T., Odermatt B., Schoenberger S.P., Ohashi P.S. Role of antigen-presenting cells in mediating tolerance and autoimmunity. J. Exp. Med. 1999;191:2021&#x2013;2028. doi: 10.1084/jem.191.11.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.191.11.2021</ArticleId><ArticleId IdType="pmc">PMC2213533</ArticleId><ArticleId IdType="pubmed">10839816</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella A.T., McCormack J.E., Linsley P.S., Kappler J.W., Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity. 1995;2:261&#x2013;270. doi: 10.1016/1074-7613(95)90050-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1074-7613(95)90050-0</ArticleId><ArticleId IdType="pubmed">7535182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehl S., Hombach J., Aichele P., R&#xfc;licke T., Odermatt B., Hengartner H., Zinkernagel R., Pircher H. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J. Exp. Med. 1998;187:763&#x2013;774. doi: 10.1084/jem.187.5.763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.187.5.763</ArticleId><ArticleId IdType="pmc">PMC2212172</ArticleId><ArticleId IdType="pubmed">9480986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig R.J., Vanhoorelbeke K., Leypoldt F., Kaya Z., Bieber K., McLachlan S.M., Komorowski L., Luo J., Marques O.C., Hammers C., et al. Mechanisms of autoantibody-induced pathology. Front. Immunol. 2017;8:603. doi: 10.3389/fimmu.2017.00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00603</ArticleId><ArticleId IdType="pmc">PMC5449453</ArticleId><ArticleId IdType="pubmed">28620373</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon K., Casali P. Nature and functions of autoantibodies. Nat. Clin. Pr. Rheumatol. 2008;4:491&#x2013;498. doi: 10.1038/ncprheum0895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncprheum0895</ArticleId><ArticleId IdType="pmc">PMC2703183</ArticleId><ArticleId IdType="pubmed">18756274</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll K.C., Hobden J.A., Miller S., Morse S.A., Mietzner T.A., Detrick B., Mitchell T.G., McKerrow J.H., Sakanari J.A. Jawetz, Melnick and Adelberg&#x2019;s Medical Microbiology. McGraw-Hill Education; New York, NY, USA: 2019. Rabies, slow virus infections, and prion diseases.</Citation></Reference><Reference><Citation>Perelygina L., Plotkin S., Russo P., Hautala T., Bonilla F., Ochs H.D., Joshi A., Routes J., Patel K., Wehr C., et al. Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. J. Allergy Clin. Immunol. 2016;138:1436.e11&#x2013;1439.e11. doi: 10.1016/j.jaci.2016.06.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.06.030</ArticleId><ArticleId IdType="pmc">PMC5392721</ArticleId><ArticleId IdType="pubmed">27613149</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorson A.E., Deen G.F., Bernstein K.T., Liu W.J., Yamba F., Habib N., Sesay F.R., Gaillard P., Massaquoi T.A., McDonald S.L.R., et al. Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: A cohort study of frequency, duration, and risk factors. PLoS Med. 2021;18:e1003273. doi: 10.1371/journal.pmed.1003273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003273</ArticleId><ArticleId IdType="pmc">PMC7875361</ArticleId><ArticleId IdType="pubmed">33566817</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitmer S.L., Ladner J.T., Wiley M., Patel K., Dudas G., Rambaut A., Sahr F., Prieto K., Shepard S.S., Carmody E., et al. Active Ebola virus replication and heterogeneous evolutionary rates in EVD survivors. Cell Rep. 2018;22:1159&#x2013;1168. doi: 10.1016/j.celrep.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.01.008</ArticleId><ArticleId IdType="pmc">PMC5809616</ArticleId><ArticleId IdType="pubmed">29386105</ArticleId></ArticleIdList></Reference><Reference><Citation>Shantha J.G., Crozier I., Yeh S. An update on ocular complications of Ebola virus disease. Curr. Opin. Ophthalmol. 2017;28:600&#x2013;606. doi: 10.1097/ICU.0000000000000426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICU.0000000000000426</ArticleId><ArticleId IdType="pmc">PMC5988239</ArticleId><ArticleId IdType="pubmed">28872492</ArticleId></ArticleIdList></Reference><Reference><Citation>Heeney J.L. Hidden reservoirs. Nature. 2015;527:453&#x2013;455. doi: 10.1038/527453a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/527453a</ArticleId><ArticleId IdType="pubmed">26607539</ArticleId></ArticleIdList></Reference><Reference><Citation>Norrby E., Kristensson K. Measles virus in the brain. Brain Res. Bull. 1997;44:213&#x2013;220. doi: 10.1016/S0361-9230(97)00139-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(97)00139-1</ArticleId><ArticleId IdType="pubmed">9323433</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Iwasaki A. Sex differences in immune responses. Science. 2021;371:347&#x2013;348. doi: 10.1126/science.abe7199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe7199</ArticleId><ArticleId IdType="pubmed">33479140</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham H., de Gruijter N.M., Raine C., Radziszewska A., Ciurtin C., Wedderburn L.R., Rosser E.C., Webb K., Deakin C.T. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun. 2020;11:1&#x2013;10. doi: 10.1038/s41467-020-19741-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19741-6</ArticleId><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Yale IMPACT Research Team. Ellingson M.K., Wong P., Israelow B., Lucas C., Klein J., Silva J., Mao T., Oh J.E., et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nat. Cell Biol. 2020;588:315&#x2013;320. doi: 10.1038/s41586-020-2700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R., Rahman M., Rassel M.A., Monayem F.B., Sayeed S.K.J.B., Islam S., Islam M.M. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS ONE. 2021;16:e0249644. doi: 10.1371/journal.pone.0249644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Team Y.I., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., et al. Diverse functional autoantibodies in patients with COVID-19. Nat. Cell Biol. 2021:1&#x2013;6. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.-S., M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan R.K., Kashour T., Hamid Q., Halwani R., Tleyjeh I.M. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front. Immunol. 2021;12:686029. doi: 10.3389/fimmu.2021.686029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A., Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861&#x2013;880. doi: 10.1016/j.cell.2021.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Wold W.S.M., Toth K. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr. Gene Ther. 2013;13:421&#x2013;433. doi: 10.2174/1566523213666131125095046.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566523213666131125095046</ArticleId><ArticleId IdType="pmc">PMC4507798</ArticleId><ArticleId IdType="pubmed">24279313</ArticleId></ArticleIdList></Reference><Reference><Citation>Munis A.M., Bentley E.M., Takeuchi Y. A tool with many applications: Vesicular stomatitis virus in research and medicine. Expert Opin. Biol. Ther. 2020;20:1187&#x2013;1201. doi: 10.1080/14712598.2020.1787981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2020.1787981</ArticleId><ArticleId IdType="pubmed">32602788</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx V. Scientists set out to connect the dots on long COVID. Nat. Methods. 2021;18:449&#x2013;453. doi: 10.1038/s41592-021-01145-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01145-z</ArticleId><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>